Liraglutide Effects on Memory in Healthy Subjects

Phase 1 Completed 40 enrolled University of Luebeck Novo Nordisk A/S · collab

RandomizedParallel-groupTriple-blindBasic science

Summary

This study examines the hypothesis, that subcutaneous administration of liraglutide, an analogue of the incretin glucagon-like peptide 1, over 5 weeks improves memory functions in healthy humans.

Timeline

Start: 2012-05
Primary completion: 2013-12
Completion: 2013-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Liraglutide	Peptide	1.2 mg	Subcutaneous

Indications

No indication recorded.